We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-19.9%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.96B
AUM Growth
-$1.09B
Cap. Flow
+$265M
Cap. Flow %
6.69%
Top 10 Hldgs %
53.12%
Holding
122
New
24
Increased
37
Reduced
35
Closed
5

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$107M
2
JD icon
JD.com
JD
+$101M
3
TCOM icon
Trip.com Group
TCOM
+$93.1M
4
HTHT icon
Huazhu Hotels Group
HTHT
+$89.8M
5
LRCX icon
Lam Research
LRCX
+$76.5M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$111M
2
BABA icon
Alibaba
BABA
+$96.9M
3
ZTO icon
ZTO Express
ZTO
+$96.3M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$94.3M
5
WB icon
Weibo
WB
+$65.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.44%
2 Technology 22.44%
3 Industrials 16.51%
4 Communication Services 15.61%
5 Healthcare 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
76
Dianthus Therapeutics
DNTH
$6.25B
$1.64M 0.04%
16,309
+3,307
+25% +$613K
ALKS icon
77
Alkermes
ALKS
$8.29B
$1.64M 0.04%
113,399
+57,514
+103% +$1.03M
PYPL icon
78
PayPal
PYPL
$50.5B
$1.57M 0.04%
16,437
– –
SGMO
79
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.57M 0.04%
245,840
+49,575
+25% +$368K
BCRX icon
80
BioCryst Pharmaceuticals
BCRX
$2.51B
$1.54M 0.04%
+771,386
New +$2.12M
AERI
81
DELISTED
Aerie Pharmaceuticals
AERI
$1.54M 0.04%
113,842
– –
PACB icon
82
Pacific Biosciences
PACB
$357M
$1.53M 0.04%
499,696
+252,221
+102% +$1.03M
BIO icon
83
Bio-Rad Laboratories Class A
BIO
$9.48B
$1.46M 0.04%
+4,175
New +$1.54M
RCUS icon
84
Arcus Biosciences
RCUS
$3.66B
$1.44M 0.04%
103,740
– –
ORCL icon
85
Oracle
ORCL
$435B
$1.42M 0.04%
29,418
– –
ALNY icon
86
Alnylam Pharmaceuticals
ALNY
$29B
$1.42M 0.04%
13,021
-2,720
-17% -$314K
CSCO icon
87
Cisco
CSCO
$483B
$1.4M 0.04%
35,700
– –
PRTA icon
88
Prothena Corp
PRTA
$468M
$1.37M 0.03%
128,223
-12,720
-9% -$154K
AAPL icon
89
Apple
AAPL
$4.5T
$1.36M 0.03%
21,448
-6,744
-24% -$496K
ALEC icon
90
Alector
ALEC
$189M
$1.36M 0.03%
56,240
-36,693
-39% -$935K
ATHM icon
91
Autohome
ATHM
$2.71B
$1.25M 0.03%
17,640
– –
ADPT icon
92
Adaptive Biotechnologies
ADPT
$4.05B
$1.24M 0.03%
+44,782
New +$1.25M
DNLI icon
93
Denali Therapeutics
DNLI
$4B
$1.24M 0.03%
+70,793
New +$1.48M
WVE icon
94
Wave Life Sciences
WVE
$1.2B
$1.18M 0.03%
126,185
+57,228
+83% +$488K
FULC icon
95
Fulcrum Therapeutics
FULC
$286M
$1.14M 0.03%
95,533
-43,234
-31% -$692K
OVID icon
96
Ovid Therapeutics
OVID
$489M
$1.14M 0.03%
382,935
+76,789
+25% +$259K
ORTX
97
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.04M 0.03%
+13,883
New +$1.6M
ZBH icon
98
Zimmer Biomet
ZBH
$18.7B
$1.04M 0.03%
+10,587
New +$1.39M
NTLA icon
99
Intellia Therapeutics
NTLA
$1.68B
$1.02M 0.03%
83,737
+17,567
+27% +$237K
ADI icon
100
Analog Devices
ADI
$187B
$961K 0.02%
10,720
– –
1 2 3
4
5

Similar funds

EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
HBFP
Henderson Brothers Financial Partners Pittsburgh, Pennsylvania $395M AUM

Platinum Investment Management's Q1 2020 Portfolio in Review

As of Q1 2020, Platinum Investment Management held 122 positions worth $3.96B, down 22% from $5.05B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Platinum Investment Management deployed $265M of net new capital in Q1 2020, opening 24 new positions and adding to 37 existing holdings. Its largest new stake was Huazhu Hotels Group: 2,640,694 shares worth $75.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $111M trimmed.

  • Platinum Investment Management's largest Q1 2020 buy was Huazhu Hotels Group: 2,640,694 shares worth $75.9M.
  • Platinum Investment Management added most to GE Aerospace in Q1 2020, an estimated $107M increase.
  • Platinum Investment Management's biggest Q1 2020 reduction was Meta Platforms (Facebook), cutting an estimated $111M.
  • Platinum Investment Management fully exited Weibo in Q1 2020, selling an estimated $65.8M.
  • Platinum Investment Management's ten largest holdings make up 53% of its $3.96B portfolio in Q1 2020.
  • Platinum Investment Management opened 24 new positions and closed 5 in Q1 2020.
  • Platinum Investment Management's portfolio value fell 22% quarter-over-quarter to $3.96B.

Based on Platinum Investment Management's 13F filing for Q1 2020, filed 15 May 2020.